Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
The young drugmaker's sickle cell treatment is receiving special consideration from the United States' top drug regulator.
Source: www.fool.com
The young drugmaker's sickle cell treatment is receiving special consideration from the United States' top drug regulator.